This activity is expired and is no longer available for CME credit.


Intravitreal Interventions®: Volume 10, Number 3

Author(s)/Faculty: Rishi P. Singh, MD; Dilsher S. Dhoot, MD; Amogh I. Iyer, BSE; Judy E. Kim, MD; Murtaza M. Mandviwala, MD; Salman Sarwar, MD; Adiel Smith, MD; Katharine E. Talcott, MD
Release Date: 8/31/2021Expiration Date: 8/30/2022
Credit Type: CMENumber of Credits: 0
Content Type: ArticleProvider:
Diagnostic techniques and technology in retinal disease continue their rapid advance, providing ophthalmologists with ever more detailed imaging information. New and emerging treatment developments have addressed the problem of frequent intravitreal injections, with new delivery systems and novel molecules with longer duration of action. It is essential that physicians stay up to date on these advances, given the evidence that patients continue to receive inadequate treatment, with the attendant risk of avoidable vision loss. The COVID-19 pandemic has also changed the way that retina specialists practice. In this issue of Intravitreal Interventions, expert clinicians discuss the latest updates in the diagnosis and treatment of retinal diseases, as well as a challenging case.